Peisong Ma on GRK5 Polymorphism Affecting Platelets
Peisong Ma, Associate Professor at Thomas Jefferson University, shared on LinkedIn:
”Excited to share that our latest manuscript, “Understanding how a highly prevalent GRK5 polymorphism affects platelets and enhances thrombotic risk,” is now published in the Blood Journal (online first).
In this study, we identify GRK5 as a previously unrecognized regulator of platelet PAR1 signaling and provide the first experimental evidence linking this common A→G variant to enhanced thrombin/PAR1 signaling and increased thrombus formation in vivo.
Using human GG donor platelets, iPSC-derived megakaryocytes, GRK5 inhibition, a humanized mouse model, and two preclinical models, our work connects human genetics → platelet GPCR regulation → thrombotic disease. These findings highlight GRK5 as a potential contributor to stroke and venous thromboembolism risk, with implications for future thrombophilia assessment.
Huge congratulations to my PhD students Yanki Yarman and Xuefei Zhao, and sincere thanks to our collaborators at Jefferson, CHOP, Cambridge, Mount Sinai, UPenn, and Purdue.”
Read the full article here.
Article: Understanding how a highly prevalent GRK5 polymorphism affects platelets and enhances thrombotic risk
Authors: Yanki Yarman, Xuefei Zhao, Hyunsook Ahn, Hannah A Thomson, Amrita Sarkar, Tian Yuan, Meghan E. Roberts, Jeremy Wurtzel, Scott L Diamond, John J.G Tesmer, Deborah L French, Maurizio Tomaiuolo, Ernest Turro, William Astle, Lawrence E. Goldfinger, Steven E. McKenzie, Jeffrey Benovic, Timothy J. Stalker, Mortimer Poncz, Peisong Ma
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 26, 2026, 18:01Kalyan Roy: Blood Group Chimerism as a Rare Cause of ABO Discrepancy
-
Sep 26, 2026, 17:34Arwa Z. Al-Riyami: Join ISBT and Advance Your Career
-
Sep 26, 2026, 16:58Paul Whiteley: Iron Deficiency and Behavioral Problems in Children With Autism
-
Sep 26, 2026, 16:41Matthew Smeds: Management of Thoracic Endograft Thrombosis and Mesenteric Embolization
-
Sep 26, 2026, 16:04Isabelle Feldhaus: What the New ASH Iron Deficiency Guidance Means for Care
-
Sep 26, 2026, 15:55Francesca Palandri: The R-NAT Score Developed in Ruxolitinib-Treated MF Patients
-
Sep 26, 2026, 15:49Alex Ehsan: Antiphospholipid Syndrome – A Practical Guide
-
Sep 26, 2026, 15:42Michael Tadao Inouye: The Next Frontier in Genomic Population Health
-
Sep 26, 2026, 15:32Katariina Öörni: Familial Hypercholesterolaemia in Children Why Early Diagnosis Matters